Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Journal of Cardiovascular Computed Tomography|October 2, 2019
Does coronary calcium score zero reliably rule out coronary artery disease in low-to-intermediate risk patients? A coronary CTA studyThomas Senoner, Fabian Plank, Christoph Beyer, et al.Journal of Cardiovascular Computed Tomography|March 7, 2019
Relationship of exercise to coronary artery disease extent, severity and plaque type: A coronary computed tomography angiography studyGudrun Feuchtner, Christian Langer, Fabian Barbieri, et al.British Journal of Haematology|April 29, 2014
PI3K-dependent multiple myeloma cell survival is mediated by the PIK3CA isoformClaudia Hofmann, Thorsten Stühmer, Nadine Schmiedl, et al.Journal of Clinical Medicine|April 3, 2021
Gender Differences in the Atherosclerosis Profile by Coronary CTA in Coronary Artery Calcium Score Zero PatientsThomas Senoner, Fabian Plank, Christoph Beyer, et al.Leukemia & Lymphoma|April 30, 2013
Next-generation sequencing of cancer consensus genes in lymphomaJennifer Hüllein, Alexander Jethwa, Tatjana Stolz, et al.British Journal of Haematology|August 19, 2009
Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800Thorsten Stühmer, Manik Chatterjee, Evelyn Grella, et al.Journal of Cardiovascular Development and Disease|November 25, 2021
Coronary Artery Dimensions in Endurance Athletes by Computed Tomography Angiography: A Quantitative AnalysisChristian Langer, Fabian Barbieri, Fabian Plank, et al.Journal of Cardiovascular Development and Disease|November 25, 2021
The Atherosclerotic Profile of a Young Symptomatic Population between 19 and 49 Years: Coronary Computed Tomography Angiography or Coronary Artery Calcium Score?Gudrun Maria Feuchtner, Christoph Beyer, Christian Langer, et al.Leukemia & Lymphoma|June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effectsLina Jansen, Maximilian Merz, Monika Engelhardt, et al.International Journal of Molecular Sciences|April 3, 2021
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 CellsMonika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, et al.Pageof 8